AGEN
Closed
Agenus Inc
4.84
+0.27 (+5.91%)
Last Update: 01 Jul 2025 23:28:00
Yesterday: 4.57
Day's Range: 4.34 - 5.05
Send
sign up or login to leave a comment!
When Written:
1.5
Agenus Inc. is a biotechnology company that develops and commercializes immunotherapies for the treatment of cancer and other diseases. The company's product pipeline includes a range of immunotherapies, including checkpoint inhibitors, cancer vaccines, and adoptive cell therapies. Agenus is also developing a proprietary technology platform called Retrocyte Display, which is designed to identify and optimize therapeutic antibodies. The company was founded in 1994 and is headquartered in Lexington, Massachusetts. Agenus is publicly traded on the NASDAQ stock exchange under the ticker symbol "AGEN".
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








